Merck
MRK
3,974 hedge funds and large institutions have $280B invested in Merck in 2026 Q3 according to their latest regulatory filings, with 306 funds opening new positions, 1,589 increasing their positions, 1,599 reducing their positions, and 112 closing their positions.
173% more first-time investments, than exits
New positions opened: 306 | Existing positions closed: 112
40% more funds holding in top 10
Funds holding in top 10: 78 → 109 (+31)
12% more call options, than puts
Call options by funds: $4.49B | Put options by funds: $4.02B
2% more funds holding
Funds holding: 3,879 → 3,974 (+95)
1% less repeat investments, than reductions
Existing positions increased: 1,589 | Existing positions reduced: 1,599
2.71% less ownership
Funds ownership: 80.81% → 78.1% (-2.7%)
41% less capital inflows, than outflows
Capital inflows: $10.9B | Capital outflows: $18.6B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.12B |
| 2 |
Fisher Asset Management
Camas,
Washington
|
+$440M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$438M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$412M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$384M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.03B |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.02B |
| 3 |
Harris Associates
Chicago,
Illinois
|
-$1.03B |
| 4 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$707M |
| 5 |
Charles Schwab
San Francisco,
California
|
-$489M |
MRK Hedge Fund Activity: Q3 2026 in Review
3,974 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2026, worth a combined $280B — up 9.4% from $256B a quarter earlier.
Buyers outnumbered sellers: 306 funds opened new MRK positions and 112 closed out — a net gain of 194 holders — while 1,589 added to existing stakes and 1,599 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $1.12B. The largest seller was Royal Bank of Canada, cutting an estimated $2.03B.
- 3,974 institutional investors held Merck (MRK) as of Q3 2026, up from 3,879 in Q2 2026.
- Funds reported $280B of Merck stock for Q3 2026, up 9.4% quarter-over-quarter.
- 306 funds opened new Merck positions in Q3 2026 and 112 closed out, a net change of +194 holders.
- The largest Merck buyer in Q3 2026 was T. Rowe Price Associates, an estimated $1.12B added.
- The largest Merck seller in Q3 2026 was Royal Bank of Canada, an estimated $2.03B sold.
Based on aggregated 13F filings for Q3 2026.